Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma

Nature Communications

Volumn 7, Issue , 2016, Pages

  Chahal, Harvind S ^a   Lin, Yuan ^b   Ransohoff, Katherine J ^a   Hinds, David A ^c   Wu, Wenting ^b   Dai, Hong Ji ^b,d   Qureshi, Abrar A ^e,f,g   Li, Wen Qing ^e,f   Kraft, Peter ^h   Tang, Jean Y ^a   Han, Jiali ^b,d,h   Sarin, Kavita Y ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c 23 and Me Inc ^*  (United States)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e BROWN UNIVERSITY   (United States)

^f BROWN UNIVERSITY   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AHR PROTEIN; AROMATIC HYDROCARBON RECEPTOR; ASIP PROTEIN; BNC2 PROTEIN; CADM1 PROTEIN; INTERFERON REGULATORY FACTOR 4; MC1R PROTEIN; OCA2 PROTEIN; SEC16A PROTEIN; SLC45A2 PROTEIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; TYR PROTEIN; UNCLASSIFIED DRUG; TUMOR PROTEIN;

CANCER; DIOXIN; GENOME; PHYSIOLOGICAL RESPONSE; SECRETION; TUMOR;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; PATHOGENESIS; PROTEIN SECRETION; SKIN CARCINOMA; SKIN PIGMENTATION; YOUNG ADULT; AGED; CASE CONTROL STUDY; CHROMOSOMAL MAPPING; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; INHERITANCE; METABOLISM; PATHOLOGY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

UNITED STATES;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INHERITANCE PATTERNS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; SKIN NEOPLASMS;

EID: 84978843011     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12048     Document Type: Article

References (51)

1. Kallini J. R., Hamed N., & Khachemoune A. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends. Int. J. Dermatol. 54, 130-140 (2015).
2. Box N. F., et al. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J. Invest. Dermatol. 116, 224-229 (2001).
3. Asgari M. M., et al. Identification of susceptibility loci for cutaneous squamous cell carcinoma. J. Invest. Dermatol. 116, 224-229 (2016).
4. Stacey S. N., et al. New common variants affecting susceptibility to basal cell carcinoma. Nat. Genet. 41, 909-914 (2009).
5. Sulem P., et al. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat. Genet. 39, 1443-1452 (2007).
6. Jacobs L. C., et al. IRF4, MC1R and TYR genes are risk factors for actinic keratosis independent of skin color. Hum. Mol. Genet. 24, 3296-3303 (2015).
7. Praetorius C., et al. A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway. Cell 155, 1022-1033 (2013).
8. Ward L. D., & Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930-D934 (2012).
9. Gudbjartsson D. F., et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40, 886-891 (2008).
10. Jacobs L. C., et al. A genome-wide association study identifies the skin color genes IRF4, MC1R, ASIP, and BNC2 influencing facial pigmented spots. J. Invest. Dermatol. 135, 1735-1742 (2015).
11. Fernandez L. P., et al. SLC45A2: a novel malignant melanoma-Associated gene. Hum. Mutat. 29, 1161-1167 (2008).
12. Duffy D. L., et al. Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J. Invest. Dermatol. 130, 520-528 (2010).
13. Nan H., Kraft P., Hunter D. J., & Han J. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int. J. Cancer 125, 909-917 (2009).
14. Visser M., Palstra R. J., & Kayser M. Human skin color is influenced by an intergenic DNA polymorphism regulating transcription of the nearby BNC2 pigmentation gene. Hum. Mol. Genet. 23, 5750-5762 (2014).
15. Eriksson N., et al. Web-based, participant-driven studies yield novel genetic associations for common traits. PLoS Genet. 6, e1000993 (2010).
16. O'Rielly D. D., et al. Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritis. Ann. Rheum. Dis. 75, 772-779 (2016).
17. Tillmann K. D., et al. Regulation of Sec16 levels and dynamics links proliferation and secretion. J. Cell Sci. 128, 670-682 (2015).
18. Ando K., et al. Expression of TSLC1, A candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation. Int. J. Cancer 123, 2087-2094 (2008).
19. Murakami Y. Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci. 96, 543-552 (2005).
20. Lu B., et al. Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway. Tumour Biol. 33, 2007-2017 (2012).
21. Chen K. M., et al. IGSF4 methylation as an independent marker of human papillomavirus-positive oropharyngeal squamous cell carcinoma. JAMA Otolaryngol. Head Neck Surg. 141, 257-263 (2015).
22. van Baars R., et al. CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies. Int. J. Cancer 138, 463-471 (2015).
23. Liu D., et al. Tumor suppressor in lung cancer 1 (TSLC1), A novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma. Tumour Biol. 34, 3773-3783 (2013).
24. Frauenstein K., et al. Evidence for a novel anti-Apoptotic pathway in human keratinocytes involving the aryl hydrocarbon receptor, E2F1, and checkpoint kinase 1. Cell Death Differ. 20, 1425-1434 (2013).
25. Contador-Troca M., et al. The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis. Carcinogenesis 34, 2683-2693 (2013).
26. Feng S., Cao Z., & Wang X. Role of aryl hydrocarbon receptor in cancer. Biochim. Biophys. Acta 1836, 197-210 (2013).
27. Karia P. S., Han J., & Schmults C. D. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J. Am. Acad. Dermatol. 68, 957-966 (2013).
28. Madeleine M. M., et al. Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res. 68, 3532-3539 (2008).
29. Hinds D. A., et al. A genome-wide association meta-Analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat. Genet. 45, 907-911 (2013).
30. Schadt E. E., et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6, e107 (2008).
31. Durand E. Y., Do C. B., Mountain J. L., & Macpherson J. M. Ancestry composition: a novel, efficient pipeline for ancestry deconvolution. Preprint at http://biorxiv.org/content/early/2014/10/18/010512 (2014).
32. Henn B. M., et al. Cryptic distant relatives are common in both isolated and cosmopolitan genetic samples. PLoS ONE 7, e34267 (2012).
33. Genomes Project C et al. A map of human genome variation from populationscale sequencing. Nature 467, 1061-1073 (2010).
34. Browning S. R., & Browning B. L. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am. J. Hum. Genet. 81, 1084-1097 (2007).
35. Fuchsberger C., Abecasis G. R., & Hinds D. A. minimac2: faster genotype imputation. Bioinformatics 31, 782-784 (2015).
36. Jorgenson E., et al. A genome-wide association study identifies four novel susceptibility loci underlying inguinal hernia. Nat. Commun. 6, 10130 (2015).
37. Hu Y., et al. GWAS of 89, 283 individuals identifies genetic variants associated with self-reporting of being a morning person. Nat. Commun. 7, 10448 (2016).
38. Hinds D. A., et al. A genome-wide association meta-Analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat. Genet. 45, 907-911 (2013).
39. Yu K., et al. Population substructure and control selection in genome-wide association studies. PLoS ONE 3, e2551 (2008).
40. Price A. L., et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
41. Johnson A. D., et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24, 2938-2939 (2008).
42. Law M. H., et al. Genome-wide meta-Analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nat. Genet. 47, 987-995 (2015).
43. Asgari M. M., Warton E. M., & Whittemore A. S. Family history of skin cancer is associated with increased risk of cutaneous squamous cell carcinoma. Dermatol. Surg. 41, 481-486 (2015).
44. Wang J., et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res. 22, 1798-1812 (2012).
45. Ward LD. HaploReg v4.0. Broad Institute (accessed September 2015).
46. Ernst J., et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43-49 (2011).
47. Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
48. Consortium EP. A user?s guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 9, e1001046 (2011).
49. Chadwick L. H. The NIH Roadmap Epigenomics Program data resource. Epigenomics 4, 317-324 (2012).
50. Consortium GT. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648-660 (2015).
51. Freidlin B., Zheng G., Li Z., & Gastwirth J. L. Trend tests for case-control studies of genetic markers: power, sample size and robustness. Hum. Hered. 53, 146-152 (2002).